Potential hazards of antifibrinolytic treatment in subarachnoid haemorrhage.
D000614:Aminocaproates / Q000009:adverse effects*; D015119:Aminocaproic Acid / Q000009:adverse effects*; D003327:Coronary Disease / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000139:chemically induced*; D012306:Risk; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy*
D000614:Aminocaproates; D015119:Aminocaproic Acid